Global Infusion Pump Market Outlook to 2030

Global Infusion Pump Market Overview

• The Global Infusion Pump market has experienced notable growth reaching a valuation of USD 17 billion in 2023. This growth is primarily driven by the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions, necessitating long-term infusion therapies.

• Major players in the infusion pump market include Baxter International Inc., B. Braun Melsungen AG, Medtronic plc, Smiths Medical, and ICU Medical, Inc. These companies dominate due to their extensive product portfolios, innovative solutions, and robust distribution networks.
• In February 2024, Medtronic plc announced the launch of their latest insulin infusion pump, the MiniMed 780G, in Europe, following its approval by the European Medicines Agency. This device features advanced glucose control algorithms and integrates with continuous glucose monitoring systems, offering patients improved glycemic management.
• In the United States, cities like New York, Los Angeles, and Chicago dominate the infusion pump market due to their large and diverse populations, advanced healthcare infrastructures, and higher prevalence of chronic diseases.

Global Infusion Pump Market Segmentation

• By Product Type: The global infusion pump market is segmented by product type into volumetric pumps, syringe pumps, ambulatory pumps, insulin pumps, and enteral pumps. In 2023, volumetric pumps held the dominant market share due to their widespread use in hospitals and clinics for delivering large volumes of fluids at precise rates.

• By Region: The global infusion pump market is segmented by region into North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East and Africa (MEA). In 2023, North America held the largest market share, primarily due to the advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative medical technologies.

• By End Use: The global infusion pump market is segmented by end user into hospitals, ambulatory surgical centers (ASCs), home healthcare, and clinics. In 2023, hospitals held the dominant market share due to their high patient turnover and the need for sophisticated and reliable infusion systems.

Global Infusion Pump Market Competitive Landscape

• Baxter International Inc.: On April 1, 2024, Baxter announced that it received U.S. FDA clearance for itsNovum IQLVP, which integrates with its existing syringe infusion pump (SYR) platform. This unified system is designed to streamline operations for healthcare providers, allowing for a common user interface and improved connectivity across different pump modalities.
• Smiths Medical: On February 14, 2024, Smiths Medical announced a Class I recall of its Medfusion Model 4000 Syringe Pump due to software issues that could lead to serious injuries or death. The recall affects over 50,000 units distributed in the U.S. since 2010.The problems are linked to earlier software versions that may compromise the device's alarm system and control features.

Global Infusion Pump Industry Analysis

Global Infusion Pump Market Growth Drivers

• Rising Incidence of Chronic Diseases: The increasing prevalence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is a major driver for the infusion pump market. Chronic diseases significantly impact healthcare expenditures, with about90% of the annual $4.1 trillionspent on healthcare in the U.S. attributed to managing and treating chronic conditions
• Growing Demand for Home Infusion Therapy: There is an increasing trend towards home healthcare, where patients prefer receiving treatments at home rather than in hospitals. In the United States, the home infusion therapy market was valued at$12.4 billion in 2023and is expected to exhibit a CAGR of10.1%from 2024 to 2032.
• Emergency Medical Needs: The need for rapid and efficient delivery of fluids and medications in emergency situations is driving the demand for infusion pumps. Infusion pumps are essential for stabilizing patient conditions in emergency situations by controlling the intravenous administration of fluids and medications.

Global Infusion Pump Market Challenges

• Product Recalls: There have been instances of product recalls due to faulty device designs, leading to injuries and even fatalities. In June 2023, Baxter Healthcare recalled nearly 23,000 infusion pumps due to software issues causing false alarms. The U.S. Food and Drug Administration (FDA) classified this as a Class I recall, indicating a risk of injury or death with continued use.
• Safety Issues: Infusion pumps are associated with significant safety concerns.The intricate design of infusion pumps, which typically necessitates several steps for programming and operation, heightens the risk of user error. Healthcare professionals are required to navigate complex menus, input exact rates, and monitor alarms, all while attending to multiple patients simultaneously.

Global Infusion Pump Market Government Initiatives

• Medical Device Regulation (MDR): The Medical Device Regulation (MDR) (EU) 2017/745 was introduced by the European Union to enhance the safety and performance of medical devices, including infusion pumps. The regulation officially came into effect onMay 26, 2021. In January 2023, the European Commission proposed an extension of the transitional provisions for compliance with the MDR due to challenges faced by manufacturers.
• FDA Infusion Pump Improvement Initiative: FDA Infusion Pump Improvement Initiative was launched in 2010 to address safety issues and reduce the number of recalls. In 2023, the FDA issued final guidance for infusion pump manufacturers, emphasizing the inclusion of detailed safety information in premarket submissions. This guidance focuses on design elements and risk mitigation strategies throughout the total product life cycle.

Global Infusion Pump Market Future Outlook

The global infusion pump market is ready for substantial growth, driven by the rising prevalence of chronic diseases, technological advancements, and increasing surgical procedures. As the market evolves, manufacturers will need to focus on innovation and compliance to capitalize on emerging opportunities.

Future Market Trends

• Expansion of Home Healthcare Services: The demand for home healthcare services is anticipated to grow significantly, driving the market for infusion pumps designed for home use. By 2028, home healthcare is expected to account for a substantial share of the infusion pump market, supported by advancements in telehealth and remote monitoring technologies.
• Growth in Emerging Markets: Emerging markets in Asia-Pacific, Latin America, and the Middle East are expected to experience rapid growth in the infusion pump market. By 2028, emerging markets will play a crucial role in the global infusion pump market, contributing significantly to its overall growth.